JC
REGN icon

JB Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

JB Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.21M Buy
8,348
+1,697
+26% +$1.16M 0.18% 67
2026
Q1 		$5.14M Buy
6,651
+62
+0.9% +$47.5K 0.21% 51
2025
Q4 		$5.09M Sell
6,589
-173
-3% -$117K 0.21% 49
2025
Q3 		$3.8M Sell
6,762
-142
-2% -$80.3K 0.16% 69
2025
Q2 		$3.62M Buy
+6,904
New +$3.85M 0.18% 66
2024
Q4 		– Sell
-332
Closed -$349K – 237
2024
Q3 		$349K Buy
332
+3
+0.9% +$3.34K 0.02% 177
2024
Q2 		$346K Buy
329
+4
+1% +$3.88K 0.02% 174
2024
Q1 		$313K Hold
325
– – 0.02% 178
2023
Q4 		$285K Hold
325
– – 0.02% 170
2023
Q3 		$267K Hold
325
– – 0.02% 157
2023
Q2 		$234K Hold
325
– – 0.02% 157
2023
Q1 		$267K Hold
325
– – 0.02% 142
2022
Q4 		$234K Buy
+325
New +$240K 0.02% 156

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JB Capital's REGN Position: Q2 2026 in Review

JB Capital increased its Regeneron Pharmaceuticals (REGN) stake by 26% in Q2 2026, buying an estimated $1.16M and bringing the position to 8,348 shares worth $5.21M. The position accounts for 0.18% of the portfolio, ranked #67.

JB Capital first reported a position in REGN in Q4 2022 and has held it in 13 quarters since. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • JB Capital held 8,348 shares of Regeneron Pharmaceuticals worth $5.21M as of Q2 2026.
  • JB Capital bought 1,697 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.16M.
  • Regeneron Pharmaceuticals made up 0.18% of JB Capital's portfolio in Q2 2026, its #67 holding.
  • JB Capital first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on JB Capital's 13F filing for Q2 2026, filed 29 Jul 2026.